Combined external beam irradiation and external regional hyperthermia for locally advanced adenocarcinoma of the prostate

International Journal of Radiation Oncology Biology Physics

Volumn 37, Issue 5, 1997, Pages 1059-1065

  Anscher, Mitchell S ^a   Samulski, Thaddeus V ^a   Dodge, Richard ^b   Prosnitz, Leonard R ^a   Dewhirst, Mark W ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CANCER INSTITUTE   (United States)

Author keywords

Hyperthermia; Prostate cancer; Radiation therapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BEAM THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; HUMAN; HYPERTHERMIC THERAPY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; RADIATION INJURY;

ADENOCARCINOMA; AGED; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY;

EID: 0030968185     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00109-0     Document Type: Article

References (29)

1. Anscher, M. S.; Samulski, T. V.; Leopold, K. A.; Oleson, J. R. Phase I/II study of external radio frequency phased array hyperthermia and external beam radiotherapy in the treatment of prostate cancer. Technique and results of intra-prostatic temperature measurements. Int. J. Radiat. Oncol. Biol. Phys. 24:489-495; 1992.
2. Astrahan, M. A.; Ameye, F.; Oyen, R.; Baert, L.; Petrovich, Z. Interstitial temperature measurements during transurethral microwave hyperthermia. J. Urol. 145:304-308; 1991.
3. Bloch, W. E.; Lokeshwar, B. L.; Ferrell, S. M.; Block, N. L. Enhancement of hyperthermic toxicity by lonidamine in the Dunning R3327G rat prostatic adenocarcinoma. Prostate 24:131-138; 1994.
4. Buchanan, M. T.; Hynynen, K. Design and experimental evaluation of an intracavitary ultrasound phased array system for hyperthermia. IEEE Trans. Biomed. Eng. 41:1178-1187; 1994.
5. Cox, D. R. Regression models and life tables. J. Royal Statis. Soc. B 34:187-220; 1972.
6. Das, S. K.; Clegg, S. T.; Anscher, M. S.; Samulski, T. V. Simulation of electromagnetically induced hyperthermia: A finite element gridding method. Int. J. Hyperthermia 11: 797-808; 1995.
7. Ebbini, E.; Umemura, S.; Ebbini, M.; Cain, C. A. A cylindrical-section ultrasound phased array applicator for hyperthermia cancer therapy. IEEE Trans. Ultrasonics, Ferroelectrics, and Frequency Control UFFC 35:561-572; 1988.
8. Fosmire, H.; Hynynen, K.; Drach, G. W.; Stea, B.; Swift, P.; Cassady, J. R. Feasibility and toxicity of transrectal ultrasound hyperthermia in the treatment of locally advanced adenocarcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 26:253-259; 1993.
9. Hancock, S. L.; Cox, R. S.; Bagshaw, M. A. Prostate specific antigen after radiotherapy for prostate cancer: A reevaluation of long-term biochemical control and the kinetics of recurrence in patients treated at Stanford University. J. Urol. 154:1412-1417; 1995.
10. Hanks, G. E. External-beam radiation therapy for clinically localized prostate cancer: Patterns of care studies in the United States. NCI Monogr. 7:75-84; 1988.
11. Kaplan, I. D.; Cox, R. S.; Bagshaw, M. A. Radiotherapy for prostate cancer: Patient selection and the impact of local control. Urology 43:634-639; 1994.
12. Kaplan, E. L.; Meier, P. Nonparametric estimation from incomplete observations. J. Am. Statis. Assoc. 53:457-481; 1958.
13. Kuban, D. A.; El-Mahdi, A. M. Local control after radiation for prostatic carcinoma: Significance and assessment. Sem. in Rad. Onc. 3:221-229; 1993.
14. Kuban, D. A.; El-Mahdi, A. M.; Schellhammer, P. F. Potential benefit of improved local tumor control in patients with prostatic carcinoma. Cancer 75:2373-2382; 1995.
15. Kuban, D. A.; El-Mahdi, A. M.; Schellhammer, P. F. Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 32:307-316; 1995.
16. Oleson, J. R.; Samulski, T. V.; Leopold, K. A.; Clegg, S. T.; Dewhirst, M. W.; Dodge, R. K.; George, S. L. Sensitivity of hyperthermia trial outcomes to temperature and time: Implications for thermal goals of treatment. Int. J. Radiat. Oncol. Biol. Phys. 25:289-297; 1993.
17. Overgaard, J.; Gonzalez Gonzalez, D.; Hulshof, M. C. C. M.; Archangeli, G.; Dahl, O.; Mella, O.; Bentzen, S. M. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet 345: 540-543; 1995.
18. Pisansky, T. M.; Cha, S. S.; Earle, J. D.; Durr, E. D.; Kozelsky, T. F.; Wieand, H. S.; Oesterling, J. E. Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer. J. Clin. Oncol. 11:2158-2166; 1993.
19. Prionas, S. D.; Kapp, D. S.; Goffinet, D. R.; Ben-Yosef, R.; Fessenden, P.; Bagshaw, M. A. Thermotherapy of interstitial hyperthermia given as an adjuvant to brachytherapy for the treatment of carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 28:151-162; 1994.
20. Russell, K. J.; Dunatov, C.; Haferman, M. D.; Griffeth, J. T.; Polissar, L.; Pelton, J.; Cole, S. B.; Taylor, E. W.; Wiens, L. W.; Koh, W. J.; Austin-Seymour, M. M.; Griffin, B. R.; Russell, A. H.; Laramore, G. E.; Griffin, T. W. Prostate specific antigen in the management of patients with localized adenocarcinoma of the prostate treated with primary radiation therapy. J. Urol. 146:1046-1052; 1991.
21. Ryu, S.; Brown, S. L.; Kim, S-H.; Khil, M. S.; Kim, J. H. Preferential radiosensitization of human prostatic carcinoma cells by mild hyperthermia. Int. J. Radiat. Oncol. Biol. Phys. 34:133-138; 1996.
22. Stamey, T. A.; Kabalin, J. N.; McNeal, J. E.; Johnstone, I. M.; Freiha, F.; Redwine, E. A.; Yang, N. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J. Urol. 141:1076-1083; 1989.
23. Stawarz, B.; Zielinski, H.; Szmigielski, S.; Rappaport, E.; Debicki, P.; Petrovich, Z. Transrectal hyperthermia as palliative treatment for advanced adenocarcinoma of prostate and studies of cell-mediated immunity. Urology 41:548-553; 1993.
24. Valdagni, R.; Amichetti, M. Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. Int. J. Radiat. Oncol. Biol. Phys. 28:163-169; 1994.
25. Vernon, C. C.; Hand, J. W.; Finst, P.; Field, S. B.; Machin, D.; Whaley, J. B.; van der Zee, J.; van Putten, W. L. J.; van Rhoon, G. C.; van Dijk, J. D. P.; Gonzalez Gonzalez, D.; Liu, F. F.; Goodman, P.; Sherar, M. Radiotherapy with or without hyperthermia in the treatment of superficial localised breast cancer - Results from five randomised controlled trials. Int. J. Radiat. Oncol. Biol. Phys. 35:731-744; 1996.
26. Wingo, P. A.; Tong, T.; Bolden, S. Cancer Statistics, 1995. CA Cancer J. Clin. 45:8-30; 1995.
27. Zagars, G. K.; Kavadi, V. S.; Pollack, A.; von Eschenbach, A. C.; Sands, M. E. The source of pretreatment serum prostate-specific antigen in clinically localized prostate cancer -T, N, or M? Int. J. Radiat. Oncol. Biol. Phys. 32:21-32; 1995.
28. Zagars, G. K.; Pollack, A.; Kavadi, V. S.; von Eschenbach, A. C. Prostate-specific antigen and radiation therapy for clinically localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 32:293-306; 1995.
29. Zeitman, A. L.; Coen, J. J.; Shipley, W. U.; Willett, C. G.; Efird, J. T. Radical radiation therapy in the management of prostatic adenocarcinoma: The initial prostate specific antigen value as a predictor of treatment outcome. J. Urol. 151:640-645; 1994.